Free Trial

Spero Therapeutics (SPRO) Insider Trading & Ownership

-0.01 (-0.66%)
(As of 05/22/2024 ET)

Spero Therapeutics (NASDAQ:SPRO) Insider Buying and Selling Activity

Insider Ownership
Number Of
Insiders Buying
(Last 12 Months)
Number Of
Insiders Selling
(Last 12 Months)
Amount Of
Insider Selling
(Last 12 Months)
Get SPRO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Spero Therapeutics stock? Sign up for's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SPRO Insider Buying and Selling by Quarter

Spero Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/13/2023Kamal HamedInsiderSell39,496$1.27$50,159.92  
8/29/2023Sath ShuklaCEOSell4,163$1.30$5,411.90  
8/28/2023Ankit MahadeviaDirectorSell9,040$1.26$11,390.40  
8/28/2023Timothy KeutzerInsiderSell1,854$1.26$2,336.04  
(Data available from 1/1/2013 forward)

SPRO Insider Trading Activity - Frequently Asked Questions

Who is on Spero Therapeutics's Insider Roster?

The list of insiders at Spero Therapeutics includes Ankit Mahadevia, Aquilo Capital Management, Llc, Kamal Hamed, Sath Shukla, and Timothy Keutzer. Learn more on insiders at SPRO.

What percentage of Spero Therapeutics stock is owned by insiders?

4.52% of Spero Therapeutics stock is owned by insiders. Learn more on SPRO's insider holdings.

Which Spero Therapeutics insiders have been selling company stock?

The following insiders have sold SPRO shares in the last 24 months: Ankit Mahadevia ($33,628.06), Aquilo Capital Management, Llc ($4,279,041.00), Kamal Hamed ($50,159.92), Sath Shukla ($28,159.35), and Timothy Keutzer ($8,648.88).

How much insider selling is happening at Spero Therapeutics?

Insiders have sold a total of 1,987,550 Spero Therapeutics shares in the last 24 months for a total of $4,399,637.21 sold.

More Insider Trading Tools from MarketBeat

This page (NASDAQ:SPRO) was last updated on 5/23/2024 by Staff

From Our Partners